1. alvinbm476
2. evililive
3. mystic494
4. dadsmith12
1.evililive 04/02/2018
Cantor Fitzgerald reiterates Buy rating, $50 PT
2.alvinbm476 02/28/2018
Misses EPS loss estimates by $0.17 and misses on revenues
3.mystic494 02/01/2018
Announces SAKURA Phase 3 clinical data to be Presented at IMCAS 2018
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW